[Form 4] Microchip Technology Inc Insider Trading Activity

Rhea-AI Filing Summary

Matthew W. Chapman, a non-employee director of Microchip Technology Incorporated (MCHP), reported stock-based transactions dated 08/18/2025. On that date 2,491 restricted stock units vested and were delivered, recorded as an acquisition at an attributed price of $65.56 per share, increasing his direct beneficial ownership to 40,665 shares. A separate grant of 3,090 restricted stock units was reported with a transaction date of 08/19/2025; each unit represents a contingent right to one share and will vest in full on the earlier of one day prior to the next annual meeting or one year from grant, subject to continued status as a non-employee director. The form was executed by an attorney-in-fact on 08/20/2025.

Positive

• 2,491 RSUs vested and were delivered, increasing the reporting director's direct holdings to 40,665 shares
• New grant of 3,090 RSUs documented with clear vesting conditions linking pay to continued non-employee director service

Negative

• None.

Insights

Financial Analyst

TL;DR Routine director RSU vesting and a new director RSU grant increased direct holdings to 40,665 shares.

The filing records a completed vesting of 2,491 restricted stock units delivered to the reporting director and a subsequent grant of 3,090 RSUs that remain contingent on continued non-employee director service. The vesting delivery increases immediate share holdings but no cash sale or purchase of open-market shares is reported. There are no disclosed cash proceeds or exercise events; the transactions are equity compensation-related and consistent with typical director award programs.

Corporate Governance Expert

TL;DR Standard non-employee director equity compensation activity; vesting is conditional on continued service.

The document clearly states the RSUs vested for one award and that another grant vests on corporate-tenure conditions tied to the next annual meeting or a one-year cliff. The filing includes the nature of indirect beneficial ownership (none reported) and shows the awards were processed via company plan mechanics. This is a routine disclosure required under Section 16 and signals standard alignment of director interests with shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHAPMAN MATTHEW W

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		M		2,491	A	$65.56	40,665	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$65.56	08/18/2025		M			2,491	(1)	(1)	Common Stock	2,491	$0	0	D
Restricted Stock Units	(2)	08/19/2025		A		3,090		(3)	(3)	Common Stock	3,090	$0	3,090	D

Explanation of Responses:

1. The restricted stock units vested in full on August 18, 2025. Vested shares were delivered to the reporting person upon vest.

2. Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.

3. The Restricted Stock Units shall vest in full on the earlier of (i) one day prior to the next annual meeting of stockholders or (ii) one year from the date of grant. All vesting of the Restricted Stock Unit Grant is contingent upon the Non-Employee Director maintaining continued status as a Non-Employee Director through the applicable vesting date.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MCHP director Matthew W. Chapman report on Form 4?

He reported that 2,491 restricted stock units vested and were delivered on 08/18/2025 and a separate grant of 3,090 RSUs was recorded on 08/19/2025.

How many shares does Matthew W. Chapman beneficially own after the reported transaction?

Following the 08/18/2025 vesting and delivery, he beneficially owns 40,665 shares directly.

What is the per-share price shown for the vested RSUs?

The transaction lists an attributed price of $65.56 per share for the vested restricted stock units.

When will the newly granted 3,090 RSUs vest?

They vest in full on the earlier of one day prior to the next annual meeting or one year from the date of grant, contingent on continued non-employee director status.

Who signed the Form 4 and when was it executed?

The form was executed by Deborah L. Wussler, as Attorney-in-Fact on 08/20/2025.